TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biolink Group AS
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
1,093
|
1,800
|
5,017 |
| Financial expenses |
1,775
|
1,591
|
1,232 |
| Earnings before taxes |
-9,602
|
-11,474
|
-11,993 |
| Total assets |
73,281
|
71,749
|
83,856 |
| Current assets |
7,717
|
9,703
|
25,639 |
| Current liabilities |
7,836
|
3,613
|
3,650 |
| Equity capital |
36,244
|
42,036
|
52,841 |
| - share capital |
5,991
|
5,991
|
5,991 |
| Employees (average) | 4 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
49.5%
|
58.6%
|
63.0% |
| Turnover per employee | 273 | ||
| Profit as a percentage of turnover |
-878.5%
|
-637.4%
|
-239.0% |
| Return on assets (ROA) |
-10.7%
|
-13.8%
|
-12.8% |
| Current ratio |
98.5%
|
268.6%
|
702.4% |
| Return on equity (ROE) |
-26.5%
|
-27.3%
|
-22.7% |
| Change turnover |
-707
|
-3,217
|
-613 |
| Change turnover % |
-39%
|
-64%
|
-11% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.